Psychotic Disorders: all 1,655 studies
Page 13 of 17. Open to participants first (298), then studies with results posted, then the rest; newest registration first within each.
- STEP-ED: Reducing Duration of Untreated Psychosis and Its Impact in the U.S.CompletedNCT02069925Not applicable
- Pharmacokinetic and Safety Study of LY03004 in Stable Patients With Schizophrenia or Schizoaffective DisorderCompletedNCT02055287Phase 1
- Randomized Controlled Trial of Aspirin vs Placebo in the Treatment of Pre-psychosisTerminatedNCT02047539Early Phase 1
- Integrated Care Including Assertive Community Treatment in Early PsychosisCompletedNCT02037581Not applicable
- Glutamate, Brain Connectivity and Duration of Untreated PsychosisCompletedNCT02034253
- Sodium Benzoate for Treatment of Attenuated/Transient Psychosis. A Randomized Placebo-controlled Trial.WithdrawnNCT02026947Phase 2
- Prevalence ， Associated Factors and Influences of Prenatal Mental DisordersStatus unknownNCT02026804
- Serial Comparisons of Abdominal and Neurological MRI ScansStatus unknownNCT02009969
- Psychosis-Associated Neuroinflammation in SchizophreniaCompletedNCT02009826
- Simvastatin Addition for Patients With Recent-onset SchizophreniaCompletedNCT01999309Phase 3
- Critical Time Intervention-Task Shifting: Randomized Controlled TrialCompletedNCT01995864Not applicable
- Application of Psychiatric Knowledge in the Rehabilitation Process in Return to Work.CompletedNCT01989767Not applicable
- Prevalence and Effect of Detecting Common Mental Disorders in Long-term Sickness AbsenceCompletedNCT01989728Not applicable
- Transcranial Direct Current Stimulation as Treatment for Auditory HallucinationsStatus unknownNCT01977521Not applicable
- Neuroendocrine and Immune Response to Stress in SchizophreniaCompletedNCT01975584Not applicable
- Cognitive Remediation for First Episode of Psychosis PatientsCompletedNCT01967420Not applicable
- Navigated αTMS in Treatment-resistant SchizophreniaActive, not recruitingNCT01941251Not applicable
- Therapeutic Effect of Quetiapine on Methamphetamine-Induced PsychosisCompletedNCT01939093Phase 4
- Thinking Skills for Work in Severe Mental IllnessCompletedNCT01926613Not applicable
- Evaluating the Cost Effectiveness of ISTDP: A Quasi Experimental StudyCompletedNCT01924715
- Brief Motivational Enhancement Therapy for Concurrent DisordersTerminatedNCT01924039Not applicable
- Interventions to Improve Functional Outcome and Persistent Symptoms in SchizophreniaCompletedNCT01915017Not applicable
- Prevention Trial of Family Focused Treatment in Youth at Risk for PsychosisCompletedNCT01907282Not applicable
- Cognitive Remediation in SchizophreniaStatus unknownNCT01903707Not applicable
- Maintenance of Efficacy With Risperidone Long Acting Injectable (R-LAI) in Patients With Schizophrenia or Schizoaffective DisorderCompletedNCT01888107Phase 3
- rTMS for Working Memory Deficits in SchizophreniaCompletedNCT01880255Not applicable
- Prospective Cytochrome P450 Genotyping and Clinical Outcomes in Patients With PsychosisCompletedNCT01878513Not applicable
- Open-label Study of Curcumin C-3 Complex in SchizophreniaCompletedNCT01875822Phase 1/2
- Cannabinoids and Cerebellar-Motor FunctioningCompletedNCT01853020Early Phase 1
- Pregnenolone and L-theanine Augmentation in the Treatment for Schizophrenia and Schizoaffective DisordersStatus unknownNCT01831986Not applicable
- Lifestyle Intervention for Diabetes and Weight Management in PsychosisCompletedNCT01828931Not applicable
- A Comparison of Paliperidone and Risperidone for Treatment of Patirnts With Methamphetamine-Associated PsychosisCompletedNCT01822730Phase 4
- Agomelatine Treatment of Depression in Schizophrenia (AGOPSYCH)CompletedNCT01822418Phase 4
- Return to Work: Promoting Health and Productivity in Workers With Common Mental DisordersCompletedNCT01805583Not applicable
- D-Serine Treatment For Tardive DyskinesiaStatus unknownNCT01804920Not applicable
- Valacyclovir Augmentation for Cognitive and Functional Remediation in SchizophreniaCompletedNCT01794897Phase 4
- Economic and Clinical Outcomes of Attendance in Psychosis Services Using SMS.Status unknownNCT01793220Not applicable
- Coaching Intervention for Patients With Early PsychosisStatus unknownNCT01792856Not applicable
- Pharmacokinetic, Safety, and Tolerability Study of Risperidone ISM® at Different Dose StrengthsCompletedNCT01788774Phase 1
- Adherence in Patients Admitted to a Psychiatric Unit for Acute Psychosis: an Analysis of Serum Levels of Antipsychotics.CompletedNCT01786369
- e-Learning & Development of an Evidence-based Psychoeducational Programme for First Episode PsychosisCompletedNCT01783457Not applicable
- Effectiveness of Adherence Therapy for SchizophreniaCompletedNCT01780116Phase 1/2
- Adherence and Quality of Life in People With Schizophrenia and Schizoaffective DisorderStatus unknownNCT01769014
- Clinical Trial to Evaluate the Efficacy of Treatment vs Discontinuation in a First Episode of Non-affective PsychosisStatus unknownNCT01765829Phase 3
- Contrasting Group Therapy Methods for PsychosisTerminatedNCT01764568Not applicable
- Correlation Between Clinical Deterioration in Schizophrenic Patients and Hair Cortisol LevelsCompletedNCT01754532
- First Episode Psychosis and Pathway to Care in NordlandCompletedNCT01753284
- Is Health Coaching Effective for Improving Metabolic Health in People With Psychosis Disorders?Status unknownNCT01752465Not applicable
- Comparison of Aripiprazole Versus Higher Metabolic Risk Antipsychotic Drugs on Adiposity Using MRICompletedNCT01739127
- Effectiveness of a Physical Activity and Diet Program in Patients With Psychotic Disorder (CapiCor)CompletedNCT01729650Not applicable
- Measuring the Effect of Remote Monitoring of Treatment Adherence on the Risk of Re-admission of Ambulatory Schizophrenic PatientsStatus unknownNCT01729572Not applicable
- The Role of Antidepressants or Antipsychotics in Preventing PsychosisWithdrawnNCT01724372Not applicable
- Niapsan as Add -on Therapy to Antipsychotic Treatment in First Episode PsychosisCompletedNCT01720095Phase 3
- Daily Intranasal Oxytocin for Childhood-Onset SchizophreniaTerminatedNCT01712646Phase 1/2
- Outcomes and Discharge of Long-stay Psychiatric PatientsCompletedNCT01701765
- Mental Health Care Provision for Adults With Intellectual Disability and a Mental DisorderCompletedNCT01695395
- Longitudinal Multimodal Neuroimaging Studies in Patients With First Episode PsychosisCompletedNCT01688765
- Understanding How Cognitive Remediation WorksCompletedNCT01683539Not applicable
- Social Cognition in Longstanding PsychosisTerminatedNCT01624831
- Effects of Cognitive Remediation on Cognition in Young People at Clinical High Risk of PsychosisCompletedNCT01619319Not applicable
- Comparison of Antipsychotic Combination Treatment of Olanzapine and Amisulpride to MonotherapyCompletedNCT01609153Phase 4
- Randomized Double Blind Placebo Control Study in Patients with SchizophreniaCompletedNCT01602029Phase 2
- Magnetic Seizure Therapy (MST) for Treatment Resistant Depression, Schizophrenia, and Obsessive Compulsive DisorderCompletedNCT01596608Not applicable
- Social Cognitive Training for Psychosis: Treatment DevelopmentCompletedNCT01579422Phase 1
- Mediators and Moderators of Treatment Outcome in Recent-Onset PsychosisCompletedNCT01570972Not applicable
- Evaluation of the "Housing First Program" in Homeless Patients With Severe Mental Disorders in FranceStatus unknownNCT01570712Not applicable
- Clinical and Genetic Factors Associated With Psychotic Symptoms Among Cocaine AbusersCompletedNCT01569347
- Transdiagnostic Group Treatments for Patients With Common Mental Disorders in Primary Health CareCompletedNCT01565213Phase 3
- The Pharmaco-genetic and Brain Mechanisms Associated With Cannabis- Induced PsychosisStatus unknownNCT01565174
- Brain Imaging, Cognitive Enhancement and Early SchizophreniaCompletedNCT01561859Not applicable
- Optimization of Treatment and Management of Schizophrenia in Europe (OPTIMISE): Substudy Site CopenhagenCompletedNCT01555814Not applicable
- Self-regulation Strategies to Improve Exercise Behavior Among Schizophrenic PatientsCompletedNCT01547026Not applicable
- Cognitive Remediation in Early Phase PsychosisStatus unknownNCT01546467Not applicable
- Pharmacologic and Clinical Testing of a D1 Agonist for Cognitive Enhancement in Neuropsychiatric DisordersCompletedNCT01519557Early Phase 1
- Clinical Validation of the Rating Scale for Psychotic Depression (RAS-PD)CompletedNCT01518049
- Theta Burst Transcranial Magnetic Stimulation as Treatment for Auditory Verbal HallucinationsCompletedNCT01512290Not applicable
- Cognitive Behavioral Therapy for Patients With an Early PsychosisCompletedNCT01511406Phase 2
- Study of the Efficacy of Adjunctive Lithium Treatment for the Treatment of Psychotic ManiaWithdrawnNCT01495156Phase 4
- Selective Estrogen Receptor Modulators (SERMs) - A Potential Treatment for Psychotic Symptoms of Schizophrenia in Men?CompletedNCT01481883Phase 4
- Genetic and Physiological Aspects of Oxidative Profile in Sleep and Well-succeed AgingCompletedNCT01480037
- Study of Mindfulness-based Group Treatment in Patients With Depression and AnxietyCompletedNCT01476371Not applicable
- N-methyl-D-aspartic Acid (NMDA) and Cognitive Remediation in SchizophreniaStatus unknownNCT01474395Phase 2
- Mental Health Engagement Network (MHEN)CompletedNCT01473550Not applicable
- POC Study of Pipamperone Added to Stable Treatment With RIS or PAL in Chronic SchizophreniaCompletedNCT01450514Phase 2
- Bergen Psychosis Project 2 - The Best Intro StudyCompletedNCT01446328Phase 4
- A Large Pragmatic Cluster Randomized Controlled Trial of a Multi-element Psychosocial Intervention for Early PsychosisCompletedNCT01436331Not applicable
- Melatonin Versus Placebo for Benzodiazepine Discontinuation in Patients With SchizophreniaCompletedNCT01431092Phase 4
- Brain Circuits in Schizophrenia and SmokingCompletedNCT01425684
- Neural Oscillations as Genetic and Functional Biomarkers in Normal and Disease StatesCompletedNCT01425671
- Epidemiology Study of PsychosisStatus unknownNCT01423669
- Decision Aid to Facilitate Shared Decision Making During Treatment in SchizophreniaTerminatedNCT01420575Not applicable
- Clinical Intervention Psychosis and AddictionStatus unknownNCT01411566Early Phase 1
- A Usability Study of a Smoking Cessation Decision Aid in People With a Recent First Episode of PsychosisCompletedNCT01399112Not applicable
- F-18 Altanserin PET Study of Patients Receiving ClozapineStatus unknownNCT01398189Not applicable
- Oxytocin Treatment of Social Cognitive and Functional Deficits in SchizophreniaCompletedNCT01394471Phase 1
- A Follow up Study of Intramuscular Olanzapine Depot in Patients With Schizophrenia or Schizoaffective DisorderStatus unknownNCT01389908Not applicable
- The Influence of the Menstrual Cycle on Lithium and Sertraline Blood LevelsCompletedNCT01385709
- Neurophysiological Studies in Schizophrenia and Psychiatric DisordersCompletedNCT01384604
- Conversion to Antipsychotic MonotherapyTerminatedNCT01368458Not applicable
- To Rescue Cognition With ValaciclovirCompletedNCT01364792Phase 2